Symbols

I-Mab Soars 10.26% on Lucid Capital Buy Rating

Generated by AI AgentAinvest Pre-Market Radar

Thursday, May 29, 2025 7:06 am ET1min read

On May 29, 2025, I-Mab's stock surged by 10.26% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Lucid Capital recently initiated a buy rating for I-MabIMAB--, setting a target price of $5. This move comes as the stock has demonstrated strong momentum, gaining over 10% in the past week and 22% year-to-date. The firm's analyst emphasized I-Mab Biopharma's focus on precision medicine and its robust pipeline of innovative therapies, which are expected to drive future growth.

Ainvest Pre-Market Radar

Get the scoop on pre-market movers and shakers in the US stock market.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue